Penn Medicine researchers are repurposing an old technique in the hopes of improving the success rate of immunotherapy for pancreatic cancer.
Related Posts
Carl June on The Boundless Potential of CAR T Cell Therapy
Carl June, MD, and Daniel Baker For most of modern medicine, cancer drugs have been developed the same way: by…
Kidney Donation Bonds Two Veterans Who Were Once Strangers
How did a kidney donation from one veteran to another originate? Morgan Slaughter saw a sign—literally. While scrolling Facebook looking…
Parkinsons Support Group Fosters Friendship Among Patients
Meeting Someone Like Me A support group at Pennsylvania Hospital not only provides resources on how to manage symptoms of…
